Literature DB >> 9544637

Long-term follow-up of patients with atopic keratoconjunctivitis.

W J Power1, I Tugal-Tutkun, C S Foster.   

Abstract

OBJECTIVE: This study aimed to review the presenting features, treatment administered to, histopathologic findings, and complications encountered in a cohort of patients with atopic keratoconjunctivitis.
DESIGN: The study design was a retrospective cohort series. PARTICIPANTS: The medical records of 20 patients with atopic keratoconjunctivitis and a minimum follow-up of 3 years were reviewed. MAIN OUTCOME MEASURES: Conjunctival and corneal complications, visual acuity before and after surgery, and histopathologic features on conjunctival biopsy were measured.
RESULTS: Significant keratopathy developed in 70% of patients, corneal neovascularization in 60%, fornix foreshortening in 25%, and symblepharon in 20% during the course of their disease. Eleven patients (12 eyes) required penetrating keratoplasty (3 for tectonic purposes and 8 for visual rehabilitation). Vision improved by four or more lines of Snellen acuity in four eyes, improved by two lines in two eyes, remained the same in five eyes, and worsened by two lines in one eye after keratoplasty. Cataract surgery was performed in seven patients (nine eyes) with vision improving by four or more lines in six patients (eight eyes).
CONCLUSION: Atopic keratoconjunctivitis is a potentially blinding disease that may result in a poor visual outcome as a result of corneal complications. Elective surgical intervention may be of benefit and can be considered in those patients whose inflammation is well controlled.

Entities:  

Mesh:

Year:  1998        PMID: 9544637     DOI: 10.1016/S0161-6420(98)94017-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  16 in total

Review 1.  Clinical correlates of common corneal neovascular diseases: a literature review.

Authors:  Nizar Saleh Abdelfattah; Mohamed Amgad; Amira A Zayed; Hamdy Salem; Ahmed E Elkhanany; Heba Hussein; Nawal Abd El-Baky
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

Review 2.  Topical ciclosporin in the treatment of ocular surface disorders.

Authors:  S Tatlipinar; E K Akpek
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

Review 3.  T helper subsets in allergic eye disease.

Authors:  Nancy J Reyes; Daniel R Saban
Journal:  Curr Opin Allergy Clin Immunol       Date:  2014-10

Review 4.  [Ocular allergies].

Authors:  E M Messmer
Journal:  Ophthalmologe       Date:  2005-05       Impact factor: 1.059

Review 5.  The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.

Authors:  J K Dart
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

6.  Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).

Authors:  Dimitri T Azar
Journal:  Trans Am Ophthalmol Soc       Date:  2006

Review 7.  [Ocular involvement in atopic dermatitis : Clinical aspects and therapy].

Authors:  P Maier; T Lapp; T Reinhard
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

8.  Atopic keratoconjunctivitis with corneal ulcer. Case report.

Authors:  Mihail Zemba; Marian Burcea; Georgiana Camburu
Journal:  Rom J Ophthalmol       Date:  2016 Jul-Sep

9.  Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis.

Authors:  M Daniell; M Constantinou; H T Vu; H R Taylor
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

10.  Surgical treatment of 32 cases of long-term atopic keratoconjunctivitis using the amniotic membrane.

Authors:  J Yang; F-H Yang; C-H Peng; D Erol; S H Tsang; X-R Li
Journal:  Eye (Lond)       Date:  2013-08-16       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.